论文部分内容阅读
目的:本文主要研究呼吸内科肺部真菌感染患者的临床表现、被感染的因素以及治疗过程等。方法:选取我院于2010年8月~2011年8月收治的130例呼吸内科肺部真菌感染患者的临床资料,遵循随机原则,将其分为两组,对照组60例,治疗组70例。治疗组患者使用氟康唑治疗,对照组患者使用伊曲康唑治疗。结果:通过分析总结,这些患者由于广谱抗生素占58.3%;呼吸内科感染由病原菌为白假丝酵母菌引起的占20.8%;糖皮质激素滥用的占12.5%、放化治疗及营养不良的占5.8%;其它因素的占2.6%。结论:采取抗真菌的综合治疗,有利于改善感染的患者的临床症状,同时需要加强营养,提高患者的免疫功能等。
Aims: This article mainly studies the clinical manifestations of pulmonary fungal infection in respiratory medicine, the factors of infection and the course of treatment. Methods: The clinical data of 130 patients with respiratory fungal pulmonary infection in our hospital from August 2010 to August 2011 were selected and randomly divided into two groups: control group (60 cases) and treatment group (70 cases) . Patients in the treatment group were treated with fluconazole, and patients in the control group were treated with itraconazole. Results: Through the analysis, these patients accounted for 58.3% due to broad-spectrum antibiotics; respiratory tract infections caused by pathogenic bacteria accounted for 20.8% of Candida albicans; glucocorticoid abuse accounted for 12.5% of radiotherapy and malnutrition accounted for 5.8%; other factors accounted for 2.6%. Conclusion: Taking anti-fungal treatment is beneficial to improve the clinical symptoms of infected patients. At the same time, it is necessary to strengthen nutrition and improve patients’ immune function.